Milnacipran (savella) for fibromyalgia

MeSH terms

• Adrenergic Uptake Inhibitors / administration & dosage
• Adrenergic Uptake Inhibitors / adverse effects
• Adrenergic Uptake Inhibitors / therapeutic use*
• Cognition / physiology
• Cyclopropanes / administration & dosage
• Cyclopropanes / adverse effects
• Cyclopropanes / therapeutic use*
• Drug Approval
• Drug Interactions
• Fibromyalgia / drug therapy*
• Fibromyalgia / psychology
• Humans
• Milnacipran
• Muscle Fatigue / drug effects
• Pain / drug therapy
• Pain / etiology
• Randomized Controlled Trials as Topic
• United States
• United States Food and Drug Administration